3020 results
Lifestyle Therapy for Diabetes - AACE 2018 Guidelines

#Lifestyle #Modifications #Therapy #Diabetes #DM2 #AACE #2018 #Guidelines #Management
for Diabetes - AACE ... #Lifestyle #Modifications ... Diabetes #DM2 #AACE
AACE/ACE ASCVD Risk Factor Modifications Algorithm

#ASCVD #RiskFactor #Modifications #Algorithm #Management #AACE
AACE/ACE ASCVD Risk ... Factor Modifications ... ASCVD #RiskFactor #Modifications ... Algorithm #Management #AACE
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... Control Algorithm #AACE
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
AACE/ACE 2016 Postmenopausal ... Evaluate for causes ... deficiency and address causes ... #Osteoporosis #AACE
Drugs Causing Acute Pancreatitis

Class Ia: The medications in which there was a rechallenge and other causes
rechallenge and other causes ... out other common causes ... Class II: Cases ... and atleast4 case ... #Pancreatitis #Causes
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
DMARDs - Treatment Modification
Causes of Erythema Nodosum - Mnemonic

NO cause found in 60% of cases
Drugs (antibiotics e.g., sulfonamides, amoxicillin)
Oral
Causes of Erythema ... Mnemonic NO cause ... found in 60% of cases ... Nodosum #Mnemonic #Causes
Pustular Skin Rash - Differential Diagnosis Algorithm
Pruritic / Scaly / Erythematous lesions, usually poorly demarcated
Acneiform -
and pustules on face ... cysts, scars on face ... thick honey-yellow crusts ... Diagnosis #Algorithm #causes
Algorithm for Management of the Overweight/Obese Patient - AACE 2018 Guidelines

#Obese #Obesity #AACE #2018 #Guidelines #Algorithm
Obese Patient - AACE ... Obese #Obesity #AACE
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Insulin Lifestyle modifications